246
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Affectionate Communication Can Suppress Immunity: Trait Affection Predicts Antibodies to Latent Epstein-Barr Virus

Pages 2-13 | Published online: 06 Mar 2014
 

Abstract

The communication of affection in close relationships has been linked empirically to multiple physical and mental health benefits that are attributable largely to its stress-alleviating effects. Because affectionate communication frequently involves tactile contact of an intimate nature, however, it may also elevate vulnerability to opportunistic illness and infection, increasing the chances for immune system suppression. Using a sample of 52 healthy adults in cohabiting romantic relationships who were seropositive for latent human herpesvirus-4 (also known as the Epstein-Barr virus), the present study documented that self-reported trait expressed affection predicts antibody titers to Epstein-Barr virus viral capsid antigen complex, indicating viral replication and suppressed cell-mediated immunity.

Additional information

Notes on contributors

Kory Floyd

Hugh Downs School of Human Communication, Arizona State University.

Colin Hesse

Department of Communication, Oregon State University.

Justin P. Boren

Department of Communication, Santa Clara University

Alice E. Veksler

Department of Communication, Christopher Newport University

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.